Abbvie Corporation
- A11 - Vitaminas
- CALCIJEX solution for injection 1 µg/1 ml
- CALCIJEX solution for injection 2 µg/1 ml
- J05 - Antivirales de uso sistémico
- HOLKIRA PAK coated tablet 250 mg - 12.5 mg+75 mg+50 mg
- KALETRA coated tablet 100 mg+25 mg
- KALETRA coated tablet 200 mg+50 mg
- KALETRA oral solution 80 mg/ml+20 mg/ml
- MODERIBA coated tablet 200 mg
- MODERIBA coated tablet 400 mg
- MODERIBA coated tablet 600 mg
- NORVIR capsule, soft 100 mg
- NORVIR oral solution 80 mg/ml
- J06 - Sueros inmunes e inmunoglobulinas
- SYNAGIS powder and solvent for solution for injection 100 mg+1 ml
- SYNAGIS powder and solvent for solution for injection 50 mg+1 ml
- L01 - Antineoplásicos
- VENCLEXTA film-coated tablet 10 mg
- VENCLEXTA film-coated tablet 100 mg
- VENCLEXTA film-coated tablet 50 mg
- L02 - Terapia endocrina
- LUPRON DEPOT powder for suspension for injection 11.25 mg
- LUPRON DEPOT powder for suspension for injection 22.5 mg
- LUPRON DEPOT powder for suspension for injection 3.75 mg
- LUPRON DEPOT powder for suspension for injection 30 mg
- LUPRON DEPOT powder for suspension for injection 7.5 mg
- LUPRON solution for injection 5 mg/ml
- L04 - Inmunosupresores
- HUMIRA PEN solution for injection 40 mg/0.8 ml
- HUMIRA solution for injection 40 mg/0.8 ml
- M03 - Relajantes musculares
- NIMBEX solution for injection 20 mg/10 ml
- N01 - Anestésicos
- ISOFLURANE ABBVIE inhalation vapour, solution 99.9%
- SEVOFLURANE AF inhalation vapour, liquid 99.97%
- N04 - Antiparkinsonianos
- DUODOPA gel for injection 20 mg/ml+5 mg/ml
- R07 - Otros productos para el sistema respiratorio
- SURVANTA endotracheopulmonary instillation, suspension 100 mg/4 ml
- SURVANTA endotracheopulmonary instillation, suspension 200 mg/8 ml